Are You Looking for a Top Momentum Pick? Why Y-mAbs Therapeutics, Inc. (YMAB) is a Great Choice
https://www.zacks.com/stock/news/2236187/are-you-looking-for-a-top-momentum-pick-why-y-mabs-therapeutics-inc-ymab-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2236187
Mar 05, 2024 - Does Y-mAbs Therapeutics, Inc. (YMAB) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Top 3 Nuveen Mutual Funds Worth Betting On for Solid Returns
https://www.zacks.com/stock/news/2235906/top-3-nuveen-mutual-funds-worth-betting-on-for-solid-returns?cid=CS-ZC-FT-best_of_funds-2235906
Mar 05, 2024 - Below, we share with you three Nuveen mutual funds, viz., FFEIX, FGIAX and NPSAX. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).
0
Why Ulta Beauty (ULTA) is a Top Stock for the Long-Term
https://www.zacks.com/stock/news/2235999/why-ulta-beauty-ulta-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2235999
Mar 05, 2024 - Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
0
3 Top-Ranked Stocks to Buy for Stability
https://www.zacks.com/commentary/2236265/3-top-ranked-stocks-to-buy-for-stability?cid=CS-ZC-FT-investment_ideas-2236265
Mar 05, 2024 - Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
0
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2235892/neuronetics-stim-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235892
Mar 05, 2024 - Neuronetics (STIM) delivered earnings and revenue surprises of 26.92% and 2.99%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2236280/plus-therapeutics-pstv-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236280
Mar 05, 2024 - Plus (PSTV) delivered earnings and revenue surprises of 10.26% and 4.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2236358/aquestive-therapeutics-aqst-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236358
Mar 05, 2024 - Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -50% and 12.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Global Business Travel Group, Inc. (GBTG) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2235944/global-business-travel-group-inc-gbtg-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235944
Mar 05, 2024 - Global Business Travel Group, Inc. (GBTG) delivered earnings and revenue surprises of -66.67% and 1.63%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2236362/gritstone-bio-inc-grts-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236362
Mar 05, 2024 - Gritstone bio Inc. (GRTS) delivered earnings and revenue surprises of 27.78% and 116.31%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Why Yum China Holdings (YUMC) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2236070/why-yum-china-holdings-yumc-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2236070
Mar 05, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0